市場調査レポート

商品コード

1574082

空カプセルの世界市場の評価：タイプ別、機能性別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Empty Capsules Market Assessment, By Type, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年10月22日
発行: Market Xcel - Markets and Data
ページ情報: 英文 230 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の空カプセルの市場規模は、2023年の35億2,000万米ドルから2031年に58億4,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで6.53%の成長が見込まれます。カプセルは、人体の特定の疾患や状態を治療するために設計された1つ以上の薬、または薬の組み合わせを含む固形の医薬品剤形です。空カプセルのもっとも一般的な用途は、薬、粉末、ハーブ、医薬品を保存することです。高齢者は、錠剤よりもカプセルの方が飲み込みやすいため、カプセルを好みます。製薬企業は薬を作り、空カプセルに入れて流通させます。カプセルの殻を作るには、プルラン、デンプン、HPMC、その他の非ゼラチン性材料が一般的に使用されます。空カプセルは、さまざまなサイズ、色合い、形状で提供されています。さらに、純水とゼラチンからなるハードゼラチンカプセルも入手可能です。不健康で座りがちな生活習慣の採用や、過度のアルコール摂取、喫煙など、複数の要因が慢性疾患の増加の主因となっています。カプセルは手頃な価格で誰でも簡単に入手でき、摂取が簡単で、慢性疾患の治療に成功しているため、その使用は今後数年で急速に増加すると予測されます。健康的なライフスタイルを送ることに対する人々の意識の高まりによる栄養補助食品の人気の高まりなど、その他の要因も市場の拡大につながっています。新たな開発と技術革新が市場拡大をもたらしています。

例えば、West Wolf Medicinalsは2024年3月、キノコエキスを配合したヴィーガンカプセルを発売すると発表しました。これはオーガニック認定を受けたカプセルです。冬虫夏草、霊芝、カワラタケ、ヤマブシタケを含む120のすずで封止されたカプセルは、環境にやさしい再生アルミニウムから作られています。

当レポートでは、世界の空カプセル市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

マーケットリーダー上位5社の競合マトリクス
上位5社のSWOT分析
主要企業上位10社の情勢
- Lonza Group Ltd.
- ACG Group
- Qualicaps
- Suheung Co., Ltd.
- CapsCanada Corporation
- Shanxi Guangsheng Medicinal Capsule Co., Ltd.
- Natural Capsules Limited
- Erawat Pharma Limited
- Nectar Lifesciences Ltd.
- Comed Chemicals Limited

第22章戦略的推奨

第23章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 4. Global Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 5. Global Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 6. Global Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 7. Global Empty Capsules Market Share (%), By Region, 2017-2031F
Figure 8. North America Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 11. North America Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 12. North America Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 13. North America Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 14. North America Empty Capsules Market Share (%), By Country, 2017-2031F
Figure 15. United States Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 18. United States Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 19. United States Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 20. United States Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 24. Canada Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 25. Canada Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 26. Canada Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 30. Mexico Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 31. Mexico Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 36. Europe Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 37. Europe Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 38. Europe Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Empty Capsules Market Share (%), By Country, 2017-2031F
Figure 40. Germany Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 43. Germany Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 44. Germany Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 45. Germany Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 46. France Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 49. France Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 50. France Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 51. France Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 55. Italy Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 56. Italy Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 57. Italy Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 61. United Kingdom Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 62. United Kingdom Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 67. Russia Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 68. Russia Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 69. Russia Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 73. Netherlands Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 74. Netherlands Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 79. Spain Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 80. Spain Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 81. Spain Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 85. Turkey Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 86. Turkey Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 91. Poland Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 92. Poland Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 93. Poland Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 94. South America Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 97. South America Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 98. South America Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 99. South America Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 100. South America Empty Capsules Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 104. Brazil Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 105. Brazil Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 110. Argentina Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 111. Argentina Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 116. Asia-Pacific Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 117. Asia-Pacific Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Empty Capsules Market Share (%), By Country, 2017-2031F
Figure 120. India Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 123. India Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 124. India Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 125. India Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 126. China Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 129. China Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 130. China Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 131. China Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 135. Japan Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 136. Japan Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 137. Japan Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 141. Australia Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 142. Australia Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 143. Australia Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 147. Vietnam Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 148. Vietnam Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 153. South Korea Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 154. South Korea Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 159. Indonesia Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 160. Indonesia Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 165. Philippines Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 166. Philippines Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 171. Middle East & Africa Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 172. Middle East & Africa Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Empty Capsules Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 178. Saudi Arabia Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 179. Saudi Arabia Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 184. UAE Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 185. UAE Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 186. UAE Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Empty Capsules Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Empty Capsules Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Empty Capsules Market Share (%), By Type, 2017-2031F
Figure 190. South Africa Empty Capsules Market Share (%), By Functionality, 2017-2031F
Figure 191. South Africa Empty Capsules Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Empty Capsules Market Share (%), By End-user, 2017-2031F
Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12120

Global empty capsules market is projected to witness a CAGR of 6.53% during the forecast period 2024-2031, growing from USD 3.52 billion in 2023 to USD 5.84 billion in 2031. Capsules are solid pharmaceutical dosage forms that contain one or more medications, or a combination of drugs designed to treat a specific illness or condition in the human body. The most common uses for empty capsules are to store medications, powders, herbs, and pharmaceuticals. The elderly population prefers capsules over tablets because they are easier to swallow. Pharmaceutical companies make their medications and package them in empty capsules for distribution. Pullulan, starch, HPMC, and other non-gelatinous materials are typically used to make the capsule shells. The empty capsules are available in a range of sizes, hues, and forms. In addition, there are hard gelatin capsules composed of pure water and gelatin that are accessible. Several factors, including the adoption of unhealthy and sedentary lifestyles, excessive alcohol consumption, and smoking, are the primary causes of growth in chronic diseases. Since capsules are easily available to everyone at affordable prices, are easy to consume, and are successful in treating chronic disorders, their use is expected to increase rapidly in the coming years. Additional factors, including the growing popularity of nutraceuticals due to rising awareness in people about living a healthy lifestyle, are also leading to market expansion. New developments and innovations are leading to market expansion.

For instance, West Wolf Medicinals announced in March 2024 that it would release vegan capsules containing mushroom extracts. It's a certified organic capsule. The 120 tin-sealed capsules containing Cordyceps, Reishi, Turkey Tail, and Lion's Mane are created from environmentally friendly recycled aluminum.

Surge in Demand for Hard-Gelatin Capsules Leading to Market Expansion

The market for empty capsules is expanding significantly due to the rise in demand for hard gelatin capsules that are made especially to protect solid contents like powders. The pharmaceutical industry's continuous efforts to boost compliance and improve drug delivery techniques are the core causes of this trend. Hard gelatin capsules are a dependable way to encapsulate solid formulations, preventing them from degrading and guaranteeing their stability until ingestion. They are generally made of gelatin or hypromellose. The capacity of hard gelatin capsules to efficiently hold and maintain solid medications is one of the main factors contributing to their growing popularity over alternative dosage forms. These capsules offer a strong protective shell against oxygen and moisture, which are vital for keeping delicate solid compositions from degrading. Consequently, to maintain the therapeutic efficacy of the drugs and increase their shelf life, pharmaceutical companies are using hard gelatin capsules more and more.

Furthermore, hard capsules improve patient compliance and convenience. They can be designed for targeted or controlled release and are simple to swallow, which enhances the patient experience overall. This is particularly crucial for older and pediatric patients, who frequently experience problems with conventional liquid or solid dosage forms. In conclusion, a major reason propelling the growth of the empty capsule market is the increasing need for hard gelatin capsules to protect solid contents. Their growing appeal in the pharmaceutical and related industries is emphasized by their capacity to protect drug stability, greater patient compliance, and formulation flexibility. For instance, Sidebyside capsule technology is transforming the hard-capsule market by offering dual-compartment capsules that can house two distinct ingredients. This innovation allows for the separation of incompatible substances or the controlled release of active components. The technology enhances formulation flexibility, improves product efficacy, and caters to personalized health needs. As a result, it boosts consumer interest and market growth in pharmaceuticals and nutraceuticals, offering a competitive edge through advanced delivery and customization options.

Growth in the Market Due to Technological Advancements

The pharmaceutical industry has experienced substantial expansion due to technological advancements that have altered the production, formulation, and use of drugs. Among the most significant technological advancements is the introduction of advanced production techniques. The production of capsules is now more accurate and efficient due to automation and precise engineering, which also ensures scalability and high standards. Due to this, producers are now able to satisfy the growing need for empty capsules for a range of medical uses. Scientific advances related to material sciences have also been very important. The development of new materials, such as plant-based and gelatin replacements, is meeting the growing consumer preference for vegetarian and vegan products. The market attractiveness and compliance among various consumer segments are increased by these materials, which are designed to offer the same stability and bioavailability as conventional gelatin capsules. Technology has also pushed improvements in capsule design, resulting in the production of specially made capsules for drug delivery systems. For example, it is now feasible to produce capsules with altered release profiles, enteric coatings, and improved dissolving qualities, which maximizes the effectiveness and patient experience in pharmaceuticals.

Customization is essential to address the unique demands of patients and healthcare professionals and promote market growth. The market for empty capsules has also benefited from the use of digital technologies in healthcare, such as telemedicine and electronic health records (EHR). The demand for exact and customized dosage forms, which capsules can effectively provide, is rising as a result of these technologies, which enable accurate prescription management and personalized medication. Moreover, advancements in analytical techniques and quality control have ensured the safety and reliability of empty capsules, boosting consumer confidence and regulatory approval. Overall, the synergy between technological innovation and the pharmaceutical industry's needs continues to drive the robust growth of the empty capsules market. For instance, Enprotect, a novel capsule solution from Lonza Group Ltd., was introduced in November 2022 to deliver ingested active pharmaceutical ingredients (APIs) that are sensitive to acidity. The company's product line expanded as a result of the introduction of this product.

Increasing Dominance of Nutraceuticals Segment Leading to Market Growth

In the upcoming years, the application sector for nutraceuticals and dietary supplements is anticipated to dominate the global market. Personalized nutrition, growing health and wellness consciousness, and shifting consumer behavior are some reasons propelling the market. Increased knowledge about preventive healthcare is one of the main drivers of the dietary supplement market. More people are realizing how crucial it is to have a balanced diet that includes all the nutrients they need to support their general health. Dietary supplements provide an easy solution for meeting certain health conditions and nutritional deficits. The aging population is another important reason for increasing the market for empty capsules and dietary supplements. The elderly population frequently chooses to take supplements to improve their general well-being and treat particular health concerns as they work to maintain their health and energy. A useful way to encapsulate unique formulas or customized dosages based on patient needs is to use empty capsules.

Nutraceuticals are frequently used by bodybuilders, fitness enthusiasts, and athletes to maximize performance, promote recovery, and meet fitness objectives. Since empty capsules are convenient, a variety of powdered supplements, such as protein powders, amino acids, and pre-workout formulations, can be conveniently encapsulated. An easy, practical, and adaptable way to take dietary supplements is with empty pharmaceutical capsules. Owing to its adaptability, customers find it simpler to include supplements in their regular routines, which supports the expansion of the nutraceuticals and dietary supplements application market. For example, LYCAGEL Flex hydroxypropyl pea starch premix was developed by Roquette Freresin in April 2024, which is one of the leading global leaders in pharmaceuticals and nutraceutical excipients. This premix was prepared for plant-based nutraceutical and pharmaceutical soft gel capsules.

North America to Dominate the Empty Capsules Market

The adoption of this dosage form by several pharmaceutical giants, plus the existence of a sizable number of businesses with high-volume capsule production capabilities, accounts for North America's supremacy. Furthermore, the growing emphasis on better medications and generics has raised the need for empty capsules. Basically, because of the expansion of the pharmaceutical and nutraceutical sectors, growing consumer awareness of nutraceutical products, and the emergence of new health-related trends in the region, North America leads this market. Additionally, the region's product demand is fueled by the government's strong support of pharmaceutical research and development, healthcare in general, and the growing need for preventative care. The demand for empty supplements and vitamin capsules has also increased due to the unfavorable changes in American lifestyles and the consequent rise in the necessity for nutraceuticals for adequate nutrient consumption. The market in the region will also be driven by the growing awareness of vegetarian empty shells (those without gelatin) and the availability of highly advanced capsule-filling machinery.

Over the course of the projection period, Canada will exhibit notable growth in the North American market. It is mostly attributable to the significant expenditures made by the major players in the production of vitamin and pharmaceutical tablets, as well as in tactical moves such as product launches and acquisitions to increase their market share. In addition, market participants in the region benefit from the increased incidence of all diseases and the growing understanding of immunity among people. For example, in April 2024, following US FDA's (Food and Drug Administration) permission, Lupin Limited introduced Oracea, the first generic version of doxycycline capsules, in the US market.

Future Market Scenario (2024-2031F)

Main factors contributing to the anticipated growth of empty capsules market are the rising geriatric population and the increasing instances of chronic diseases. However rising awareness in people about boosting immunity is also driving the market. This is an ever-growing trend that not only positively affects people's lifestyles but also rise the market of capsules. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an un-paralleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion. For instance, one of the Operio Group LLC's brands, Vivion, Inc., announced in February 2023 the launch of optimal product ranges of pullulan, HPMC, and empty gelatin capsules.

Key Players Landscape and Outlook

Several companies such as Lonza Group Ltd., ACG Group, Qualicaps, Suheung Co., Ltd., CapsCanada Corporation, Shanxi Guangsheng Medicinal Capsule Co., Ltd., Natural Capsules Limited, Erawat Pharma Limited, Nectar Lifesciences Ltd., Comed Chemicals Limited, etc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed empty capsules to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, ACG Company's Vantage Nutrition LLC purchased South Africa's BioCap GmbH and the US's ComboCap, Inc. to increase its technology and global reach in March 2023.

The manufacturing facilities of Akums Drug & Pharmaceuticals Ltd., located in Haridwar, India, for empty hard gelatin capsules were licensed in July 2022. This European Union-based (EU-based) company is known to adopt Good Manufacturing Practices (GMP).

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Empty Capsules Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share & Forecast
- 4.2.1. By Type
  - 4.2.1.1. Gelatin Capsules
    - 4.2.1.1.1. Porcine Gelatin Capsules
    - 4.2.1.1.2. Bovine Gelatin Capsules
    - 4.2.1.1.3. Others
  - 4.2.1.2. Non-Gelatin Capsules
    - 4.2.1.2.1. Hydroxypropyl Methyl Cellulose Capsules
    - 4.2.1.2.2. Pullulan and Starch Capsules
- 4.2.2. By Functionality
  - 4.2.2.1. Immediate-Release Capsules
  - 4.2.2.2. Sustained-Release Capsules
  - 4.2.2.3. Delayed-Release Capsules
- 4.2.3. By Application
  - 4.2.3.1. Pharmaceutical Applications
    - 4.2.3.1.1. Antibiotic and Antibacterial Drugs
    - 4.2.3.1.2. Vitamins and Dietary Supplements
    - 4.2.3.1.3. Antacids and Antiflatulent Preparations
    - 4.2.3.1.4. Cardiovascular Therapy Drugs
    - 4.2.3.1.5. Anti-Inflammatory Drugs
    - 4.2.3.1.6. Others
  - 4.2.3.2. Nutraceutical Applications
- 4.2.4. By End-user
  - 4.2.4.1. Pharmaceutical Industries
  - 4.2.4.2. Nutraceutical Industries
  - 4.2.4.3. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share (%), 2023
4.3. Market Map Analysis, 2023
- 4.3.1. By Type
- 4.3.2. By Functionality
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Empty Capsules Market Outlook, By Region, 2017-2031F

5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share & Forecast
- 5.2.1. By Type
  - 5.2.1.1. Gelatin Capsules
    - 5.2.1.1.1. Porcine Gelatin Capsules
    - 5.2.1.1.2. Bovine Gelatin Capsules
    - 5.2.1.1.3. Others
  - 5.2.1.2. Non-Gelatin Capsules
    - 5.2.1.2.1. Hydroxypropyl Methyl Cellulose Capsules
    - 5.2.1.2.2. Pullulan and Starch Capsules
- 5.2.2. By Functionality
  - 5.2.2.1. Immediate-Release Capsules
  - 5.2.2.2. Sustained-Release Capsules
  - 5.2.2.3. Delayed-Release Capsules
- 5.2.3. By Application
  - 5.2.3.1. Pharmaceutical Applications
    - 5.2.3.1.1. Antibiotic and Antibacterial Drugs
    - 5.2.3.1.2. Vitamins and Dietary Supplements
    - 5.2.3.1.3. Antacids and Antiflatulent Preparations
    - 5.2.3.1.4. Cardiovascular Therapy Drugs
    - 5.2.3.1.5. Anti-Inflammatory Drugs
    - 5.2.3.1.6. Others
  - 5.2.3.2. Nutraceutical Applications
- 5.2.4. By End-user
  - 5.2.4.1. Pharmaceutical Industries
  - 5.2.4.2. Nutraceutical Industries
  - 5.2.4.3. Others
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Graphics Card Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Type
      - 5.3.1.2.1.1. Gelatin Capsules
      - 5.3.1.2.1.1.1. Porcine Gelatin Capsules
      - 5.3.1.2.1.1.2. Bovine Gelatin Capsules
      - 5.3.1.2.1.1.3. Others
      - 5.3.1.2.1.2. Non-Gelatin Capsules
      - 5.3.1.2.1.2.1. Hydroxypropyl Methyl Cellulose Capsules
      - 5.3.1.2.1.2.2. Pullulan and Starch Capsules
    - 5.3.1.2.2. By Functionality
      - 5.3.1.2.2.1. Immediate-Release Capsules
      - 5.3.1.2.2.2. Sustained-Release Capsules
      - 5.3.1.2.2.3. Delayed-Release Capsules
    - 5.3.1.2.3. By Application
      - 5.3.1.2.3.1. Pharmaceutical Applications
      - 5.3.1.2.3.1.1. Antibiotic and Antibacterial Drugs
      - 5.3.1.2.3.1.2. Vitamins and Dietary Supplements
      - 5.3.1.2.3.1.3. Antacids and Antiflatulent Preparations
      - 5.3.1.2.3.1.4. Cardiovascular Therapy Drugs
      - 5.3.1.2.3.1.5. Anti-Inflammatory Drugs
      - 5.3.1.2.3.1.6. Others
      - 5.3.1.2.3.2. Nutraceutical Applications
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Pharmaceutical Industries
      - 5.3.1.2.4.2. Nutraceutical Industries
      - 5.3.1.2.4.3. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Empty Capsules Market Outlook, 2017-2031F

6.1.1. Germany
6.1.2. France
6.1.3. Italy
6.1.4. United Kingdom
6.1.5. Russia
6.1.6. Netherlands
6.1.7. Spain
6.1.8. Turkey
6.1.9. Poland

7. Asia-Pacific Empty Capsules Market Outlook, 2017-2031F

7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. Australia
7.1.5. Vietnam
7.1.6. South Korea
7.1.7. Indonesia
7.1.8. Philippines

8. South America Empty Capsules Market Outlook, 2017-2031F

8.1.1. Brazil
8.1.2. Argentina

9. Middle East and Africa Empty Capsules Market Outlook, 2017-2031F

9.1.1. Saudi Arabia
9.1.2. UAE
9.1.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Lonza Group Ltd.
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. ACG Group
- 21.3.3. Qualicaps
- 21.3.4. Suheung Co., Ltd.
- 21.3.5. CapsCanada Corporation
- 21.3.6. Shanxi Guangsheng Medicinal Capsule Co., Ltd.
- 21.3.7. Natural Capsules Limited
- 21.3.8. Erawat Pharma Limited
- 21.3.9. Nectar Lifesciences Ltd.
- 21.3.10. Comed Chemicals Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

空カプセルの世界市場の評価：タイプ別、機能性別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Empty Capsules Market Assessment, By Type, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の空カプセル市場の見通し（2017年～2031年）

第5章 北米の空カプセル市場の見通し：地域別（2017年～2031年）

第6章 欧州の空カプセル市場の見通し（2017年～2031年）

第7章 アジア太平洋の空カプセル市場の見通し（2017年～2031年）

第8章 南米の空カプセル市場の見通し（2017年～2031年）

第9章 中東・アフリカの空カプセル市場の見通し（2017年～2031年）

第10章 需給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

第19章 特許情勢

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的推奨

第23章 当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Empty Capsules Market Outlook, 2017-2031F

5. North America Empty Capsules Market Outlook, By Region, 2017-2031F

6. Europe Empty Capsules Market Outlook, 2017-2031F

7. Asia-Pacific Empty Capsules Market Outlook, 2017-2031F

8. South America Empty Capsules Market Outlook, 2017-2031F

9. Middle East and Africa Empty Capsules Market Outlook, 2017-2031F

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の空カプセル市場の見通し（2017年～2031年）

第5章北米の空カプセル市場の見通し：地域別（2017年～2031年）

第6章欧州の空カプセル市場の見通し（2017年～2031年）

第7章アジア太平洋の空カプセル市場の見通し（2017年～2031年）

第8章南米の空カプセル市場の見通し（2017年～2031年）

第9章中東・アフリカの空カプセル市場の見通し（2017年～2031年）

第10章需給分析

第11章輸入と輸出の分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第15章価格分析

第16章市場力学

第17章市場の動向と発展

第18章規制枠組みとイノベーション

第19章特許情勢

第20章ケーススタディ

第21章競合情勢

第22章戦略的推奨

第23章当社について、免責事項